Molecular investigation of secondary chronic myeloid leukemia

Blood. 1996 Oct 1;88(7):2808-9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Combined Modality Therapy / adverse effects
  • DNA, Neoplasm
  • Genes, Tumor Suppressor*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Male
  • Neoplasms, Second Primary / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational
  • Radiotherapy / adverse effects
  • Seminoma / therapy
  • Testicular Neoplasms / therapy
  • Thymoma / therapy
  • Thymus Neoplasms / therapy

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm